Skip to main content
. Author manuscript; available in PMC: 2023 Apr 25.
Published in final edited form as: Nat Chem Biol. 2022 Sep 29;19(3):275–283. doi: 10.1038/s41589-022-01149-6

Fig. 2 |. Dose-response of drugs screened against SARS-CoV-2.

Fig. 2 |

Dose-response curves showing the EC50 of each compound against SARS-CoV-2 (% infected cells, blue), total cell counts (orange) in the infection experiment and the CC50 for uninfected host cell toxicity (magenta), as assessed in HeLa-ACE2 cells. See also Supplementary Data Set 1 for full dataset.